Bio-Techne (TECH) FY2024 results: revenue $1.2 billion, up 2.0% on the year
Bio-Techne Corp. (TECH) reported revenue of $1.2 billion for fiscal 2024, the year ended 30 June 2024, up 2.0% on the year before. Net income was $168 million, down 41.1%, and diluted earnings per share $1.05. The figures are the company's own, from the 10-K it filed with the SEC on 22 August 2025.
Revenue
$1.2 billion
+2.0% on the year
FY2017FY2024
Operating margin
17.8%
26.3% a year earlier
FY2017FY2024
Net income
$168 million
-41.1% on the year
FY2017FY2024
Diluted EPS
$1.05
-40.3% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
299
254
325
+17.5%
Capital expenditure
62.9
38.2
44.9
+64.4%
Free cash flow
236
216
280
+9.2%
Free cash flow margin
20.4%
19.0%
25.4%
Cash from investing
-203
-266
-96.9
Cash from financing
-122
22.6
-243
Depreciation and amortisation
112
107
101
+4.2%
Share-based compensation
38.0
39.2
42.2
-3.0%
Buybacks
80.0
19.6
161
+309.2%
Dividends paid
50.4
50.3
50.2
+0.3%
Dividend per share
$0.32
$0.32
$0.32
0.0%
Diluted shares, weighted
161m
162m
164m
-0.7%
Shares outstanding at period end
158m
158m
157m
+0.4%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
2,069
1,967
1,702
+5.2%
Non-controlling interest
n/a
n/a
-0.8
Debt
319
350
256
-8.9%
Operating lease liabilities
87.6
93.8
58.1
-6.6%
Other liabilities
228
228
280
-0.0%
Total liabilities and equity
2,704
2,639
2,295
+2.5%
Fixed assets
251
226
223
+11.0%
Goodwill
973
873
822
+11.4%
Intangible assets
507
535
532
-5.2%
Investments
1.1
23.7
74.5
-95.5%
Cash and equivalents
152
181
173
-15.9%
Receivables
241
218
195
+10.5%
Inventory
180
172
141
+4.7%
Other assets
399
411
135
-2.9%
Total assets
2,704
2,639
2,295
+2.5%
10-K for the year ended 30 June 2024, filed 22 August 2025: the filing.